Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancer immunotherapy by disrupting PD-1/PD-L1 signaling

Cancer immunotherapy by disrupting PD-1/PD-L1 signaling

US Patent 10584170 · Granted Mar 10, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PD-1 antibodies and uses thereof2025
Treatment of cancer2025
PD-L1 binding polypeptides for imaging2025
Anti-IDO antibody and uses thereof2024
Treatment of LAG-3 positive tumors2024
Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leuk2024
Bispecific antibody against CD3 and CD20 in combination therapy for treating dif2023
Treatment of LAG-3 positive tumors2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating fol2023
Antibodies against OX-40 and uses thereof2022
Anti-GITR antibodies for cancer diagnostics2022
Antibodies against CD73 and uses thereof2022